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Objective: The purpose of the study was to examine the effects of a 12-month exercise program on lower limb mobility
(temporal-spatial gait parameters and gait kinematics), walking performance, peak physiological responses, and physical
activity levels in individuals with symptoms of intermittent claudication due to peripheral arterial disease (PAD-IC).
Methods: Participants (n  21) with an appropriate history of PAD-IC, ankle-brachial pressure index (ABI) <0.9 in at
least one leg and a positive Edinburgh claudication questionnaire response were prospectively recruited. Participants were
randomly allocated to either a control PAD-IC group (CPAD-IC) (n  11) that received standard medical therapy and
a treatment PAD-IC group (TPAD-IC) (n  10), which also took part in a 12-month supervised exercise program. A
further group of participants (n  11) free of PAD (ABI >0.9) and who were non-regular exercisers were recruited from
the community to act as age and mass matched controls (CON). Lower limb mobility was determined via two-
dimensional video motion analysis. A graded treadmill test was used to assess walking performance and peak physiological
responses to exercise. Physical activity levels were measured via a 7-day pedometer recording. Differences between groups
were analyzed via repeated measures analysis of variance (ANOVA).
Results: The 12-month supervised exercise program had no significant effect on lower limb mobility, peak physiological
responses, or physical activity levels in TPAD-IC compared with CPAD-IC participants. However, the TPAD-IC
participants demonstrated significantly greater walking performance (171% improvement in pain free walking time and
120% improvement in maximal walking time compared with baseline).
Conclusion: The results of this study confirm that a 12-month supervised exercise programwill result in improved walking
performance, but does not have an impact on lower limb mobility, peak physiological responses, or physical activity levels
of PAD-IC patients. ( J Vasc Surg 2008;47:303-9.)Patients with symptoms of intermittent claudication
due to peripheral artery disease (PAD-IC) have reduced
walking performance, peak physiological responses, lower
limb mobility (temporal-spatial gait parameters and gait
kinematics), physical activity levels, and perceived health
related quality of life (QOL) compared with healthy age-
matched controls.1-5 PAD-IC is usually treated conserva-
tively with medications to reduce cardiovascular disease
risk-factors; however, patients often continue to have im-
paired QOL. For severe PAD-IC, surgery is often the most
appropriate treatment for QOL outcomes.6,7 Regardless of
the initial treatment, PAD-IC patients are encouraged to
increase their physical activity levels, thereby reducing the
risk factors associated with the condition.8
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doi:10.1016/j.jvs.2007.10.038PAD-IC patients have been reported to walk signifi-
cantly further following a 3-month supervised exercise pro-
gram consisting of intermittent walking.9 Although exer-
cise programs have demonstrated improved walking
performance,9-11 the exact mechanisms for the improve-
ment have not been demonstrated. Increased cardiac out-
put, development of collateral lower limb arteries, im-
proved efficiency of oxygen delivery, adaptation of muscle
metabolism, and changes in lower limb mobility6,12 have
been suggested as contributors to improved walking per-
formance; however, there is no consensus as to the major
contributing factors.
Most PAD-IC studies have employed short-term exer-
cise programs.9-11,13 To date, there have been only two
studies that investigated the effects of a longer (12 months)
term exercise program on walking performance in PAD-IC
patients.14 Important factors such as the duration and
intensity of the exercise may be central to improved walking
performance. Also, there has been no long-term examina-
tion of the lower limb mobility of individuals with PAD-IC
in order to determine if the reduced lower limb mobility in
this population can be modified to more closely resemble
healthy age-matched controls. Gardner et al3 speculated
that the reduced temporal-spatial gait parameters could be
303
JOURNAL OF VASCULAR SURGERY
February 2008304 Crowther et almodified to resemble that of age-matched controls through
the use of an exercise program.
Therefore, the aim of this study was to examine the
effects of a 12-month supervised exercise program on the
lower limb mobility of individuals with PAD-IC during
pain free walking. A further aim was to examine the extent
to which lower limb mobility contributes to long-term
exercise induced changes in walking performance, peak
physiological responses, and physical activity levels in
PAD-IC patients. It was hypothesized that a long-term
supervised exercise program would result in improved
lower limb mobility during pain free walking, which in turn
would be reflected in improved functional capacity; that is,
improved walking performance, increased peak physiolog-
ical responses to acute exercise, and augmented levels of
physical activity.
METHODS
Participants
Between January 2003 and 2006, patients referred to
the vascular department at the Townsville Hospital with
symptoms of intermittent claudication were considered for
inclusion in the study. Entry criteria included an appropri-
ate history of intermittent claudication, imaging confirma-
tion of PAD on lower limb duplex or computed tomo-
graphic angiograph (CTA), and ability and willingness to
attend regular supervised exercise. Approximately 50% of
patients attending our vascular department live 200 km
away. Thus, the main reason for excluding patients was the
inability to attend the program (n  48). Other reasons for
exclusion included selection for surgical or endovascular
intervention (n  30), patient preference (n  20), and
requirement for mobility aids, obvious gait abnormalities
Table I. Descriptive characteristics of participants
Variable
CON (n  11)
0 mo 12 mo
Age (y) 68.1 (6.8) 69.4 (6.9)
Height (cm) 167.8 (8.2) 167.9 (8.1)
Mass (kg) 70.7 (8.4) 68.9 (8.0)
Body fat (%) 31.6 (9.5) 29.0 (8.5)
BMI 25.2 (3.2) 24.5 (2.8)
ABI left leg* 1.18 (0.16) 1.18 (0.10)
ABI right leg* 1.16 (0.13) 1.12 (0.16)
Gender (% male) 45
Current smoker (%) 0
Former smoker (%) 27
Type II diabetes (%) 0
Hypertension (%) 9
Ischemic heart disease (%) 0
Arthritis (%) 27
Beta-blocker prescription (%) 0
CON, Healthy age and mass matched controls; CPAD-IC, control peri
peripheral arterial disease-intermittent claudication patients; ABI, ankle-bra
Values are mean (SD) or %.
*P  .01 between group CON vs CPAD-IC and TPAD-IC.
†P  .01 vs CON.(eg, circumduction) or medical conditions that influencedgait (eg, orthopedic conditions and neurological impair-
ment) (n  20). All patients were assessed by a consultant
vascular physician. PAD-IC was confirmed by absence of
peripheral pulses, lower limb artery stenosis, or occlusion
on duplex or CTA, ankle-brachial pressure index (ABI)
0.9 and positive Edinburgh Claudication Questionnaire
response.15 Five participants withdrew from the study fol-
lowing baseline testing citing health, changed address, and
personal motivation reasons. Participants were randomly
allocated using a double blind protocol to either a control
(CPAD-IC, n  11) or treatment group (TPAD-IC, n 
10). All participants were reviewed by a vascular surgeon
and consultant physician to optimize their atherosclerosis
risk factor management, which included recommendations
to modify smoking habits, diet, medication, and to under-
take regular physical activity. Patients randomized to the
TPAD-IC experimental condition also undertook a 12-
month supervised exercise program. A third group of par-
ticipants (n  11) free of PAD based on normal ABI and
peripheral pulses and who were non-regular exercisers were
recruited from the general community via e-mail bulletin
boards, local newspaper, and television coverage to act as
age and mass matched controls (CON). Comorbidity,
medication, and smoking history were determined at con-
sultation by a vascular physician. All participants volun-
teered and gave written informed consent to participate in
this study as approved by the institutional ethics commit-
tee. The descriptive characteristics of the participants are
outlined in Table I.
Procedure
Participants arrived at the laboratory in the early morn-
CPAD-IC (n  11) TPAD-IC (n  10)
0 mo 12 mo 0 mo 12 mo
.1 (6.8) 68.1 (6.8) 71.3 (8.5) 72.3 (8.5)
.6 (8.7) 165.4 (8.9) 165.7 (8.9) 165.7 (9.5)
.5 (18.9) 74.5 (18.8) 80.7 (15.3) 81.3 (15.3)
.4 (8.6) 32.7 (8.9) 33.1 (9.0) 35.1 (6.5)
.9 (5.3) 27.0 (5.2) 29.2 (4.1) 29.5 (4.3)
64 (0.22) 0.64 (0.23) 0.72 (0.22) 0.68 (0.17)
69 (0.27) 0.60 (0.21) 0.71 (0.23) 0.67 (0.21)
45 50
27 10
64† 70†
27 10
36 30
27 20
18 10
45† 10
l arterial disease-intermittent claudication patients; TPAD-IC, treatment
ndex; BMI, body mass index.67
165
74
30
26
0.
0.
phera
chial iing whilst in a fasting state (12 hours) and underwent, body
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testing at 0 and 12 months.
Anthropometry. Participant height was determined
by a wall mounted stadiometer (Seca, model 220, Seca
Scales, Hamburg, Germany). Body mass and composition
(% body fat) were determined via bioelectrical impedance
scales (TANITA TBF 521, TANITA Corporation, Arling-
ton Heights, Ill). Body mass index (BMI) was calculated as
(mass in kg/[(height in m)2]).
Ankle-brachial index (ABI). Blood pressure mea-
surements were taken by a qualified sonographer using a
handheld bidirectional Doppler instrument (MD6, Ho-
kanson, Bellevue, Wash) with a 5-MHz transducer and
standard blood pressure cuffs after the participant had
rested in the supine position for 10 minutes. ABI was
calculated as the highest systolic blood pressure in the
posterior tibial artery or dorsalis pedis artery divided by the
highest systolic blood pressure in the left or right brachial
artery.16
Lower limb mobility. Major joint segments were
identified using reflective markers placed on five landmarks
on the ipsilateral (right side) of the participant’s body. The
landmarks were determined via palpation, and the markers
were positioned at the shoulder (acromion), hip (greater
trochanter of femur), knee (lateral epicondyle of femur),
ankle (lateral malleolus of fibula), and head of the fifth
metatarsal.
Participants were instructed to walk normally without
shoes along a 10 m walkway that was marked at 1 cm
intervals whilst the participant was in a pain free state.
Digital imagery was obtained via a high-speed digital video
camera (Canon MV550i, Canon Australia, North Ryde,
Australia) set at a frame rate of 50 Hz and placed 3 m
perpendicular to the line of motion providing an uninter-
rupted video field. Five complete trials were achieved. A
walking trial was deemed to be complete and suitable for
analysis if all anatomical markers were visible at the first and
last ipsilateral heel strike. Three walking trials (one stride
per trial) were then randomly selected for kinematic analy-
sis.17 During the recording of video footage, digital images
were captured via a video capture card (Adaptec FireCon-
nect for Notebooks, Adaptec Inc, Milpitas, Calif) and
appropriate lower limb joints were identified and named
with digitizing software (SiliconCoach Ltd, Dunedin, New
Zealand) operating on a laptop computer (Toshiba PIV,
Toshiba Australia, North Ryde, Australia).
Two markers were placed 1 m apart on the floor in the
direction of travel in order to calibrate the digitizing soft-
ware. The first author performed all digitizing of the digital
video images in order to prevent inter-individual variability
in anatomical marker identification. The intraclass correla-
tion coefficient (ICC) values for the digitized X and Y
coordinate data ranged from 0.9 to 0.95. The ICC data for
within-participant gait kinematic measures ranged from 0.8
to 0.85.
Data points were used to calculate gait kinematic pa-
rameters including peak displacements, velocities, and ac-
celeration for the ipsilateral lower limb joints. The figureoutlines the joint angle conventions used to determine the
kinematic variables. Temporal-spatial gait parameters de-
termined included stride length, stride cadence, contact
time, flight time, initial double support time, ipsilateral leg
support time, final double support time, contralateral leg
support time, total time, and speed. Stride length was
calculated as the distance from successive initial ground
contacts of the ipsilateral foot.
Treadmill testing. Following lower limb mobility as-
Fig. Joint angle conventions.sessment, participants undertook a graded exercise test on a
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for determination of walking performance and physiologi-
cal responses to acute exercise. The peak physiological
responses included oxygen uptake (VO2peak), respiratory
exchange ratio (RERpeak), ventilation (VEpeak), and heart
rate (HRpeak). The physiological responses were deter-
mined via indirect calorimetry using a metabolic cart
(Power LAB/8M Metabolic System, AD Instruments Pty
Ltd, Castle Hill, Australia). The metabolic gas analysis
system was calibrated with a 3 L syringe, temperature
(°C), barometric pressure (mm Hg), airflow (L), body mass
(kg), room air (20.93% and 0.03% for O2 and CO2, respec-
tively), and alpha gas composition (10% O2, 7% CO2)
(BOC, Melbourne, Australia). Before the test began, the
participant was fitted with a headpiece that held a rubber
mouthpiece connected to a T-shaped two-way non-re-
breathing value (Hans Rudolph, Inc, Kansas City, Mo),
which in turn was connected to the mixing chamber of the
metabolic gas analysis system by 35 mm diameter smooth
bore hosing. Electrocardiogram electrodes (silver/silver
chloride electrodes, 3M, Pymble, Australia) were posi-
tioned at the manubrium, seventh cervical vertebrae and
fifth intercostal-axiliary line (lead II) for the recording of an
electrocardiogram. All physiological responses were re-
corded continuously using Chart (v5.1, AD Instruments
Pty Ltd, Castle Hill, Australia) sampling at 1000 Hz and
were analyzed post test as 15-second averages.
The graded treadmill walking protocol consisted of a
constant speed of 3.2 km·h1 and an incline of 0% for the
first 2 minutes, which was then increased by 2% every 2
minutes.18 Participant perception of exercise exertion was
determined every 60 seconds via Borg’s19 Rating of Per-
ceived Exertion (RPE) instrument while participant per-
ception of claudication pain was determined via a 5-point
(0  no pain, 1  onset of pain, 2  moderate pain, 3 
intense pain, 4  maximal pain) claudication pain scale
(CPS).20 Walking performance was assessed as pain free
walking time (PFWT) and maximal walk time (MWT)
either by perceived maximal pain, volitional exhaustion, or
until 25 minutes of walking was achieved. Participants were
permitted to hold the treadmill handrail if they required
support whilst walking and a number of common motiva-
tional phrases (eg, you can make it, keep walking) were
used to encourage participants. Motivational phrase usage
was standardized by noting the frequency and type of
phrase used in pilot and preliminary testing. Exercise test
termination criteria included voluntary exhaustion and sig-
nificant abnormal ECG rhythm.
Physical activity level. Following laboratory testing,
participant physical activity levels were determined from
7-day pedometer (YAMAX DigiWalker SW-700, YAMAX
Corporation, Tokyo, Japan) recordings. Physical activity
level was determined as number of steps, distance walked,
and calories expended during walking. The TPAD-IC par-
ticipants did not wear a pedometer during supervised exer-
cise sessions in order to allow between group comparisons
of physical activity levels outside the laboratory.Supervised exercise program. The exercise program
initially consisted of supervised treadmill walking 3 d·wk1
for 25 minutes at 3.2 km·hr1. Participants were required
to walk until the pain level was perceived as being 3 or 4 on
the CPS. Exercise intensity (via treadmill grade and walking
speed) and duration (25 up to 40 minutes) was progres-
sively increased once the participant could walk without
stopping for 25 minutes below the pain CPS levels of 3 or
4. This exercise progression strategy was continued over
the 12-month period.
Statistical analyses
Statistical analysis was performed using the SPSS (SPSS
Inc, release 14.0, Chicago, Ill) software program. Descrip-
tive statistics were expressed as mean (SD). Box-plot
analyses were performed to identify extreme and outlier
data. Data were analyzed using repeated measures analysis
of variance (ANOVA) with one between-subjects factor
(CON versus CPAD-IC versus TPAD-IC) and one within
subject factor (time - 0 versus 12 months). Post hoc analysis
was performed using the Tukey HSD test. Medication and
comorbidities data were analyzed using the nonparametric
Friedman test and post hoc comparison using Nemenyi’s
test. An alpha level of .05 was adopted for this study.21
RESULTS
Participants. The groups were similar in age, height,
mass, % body fat, and BMI at baseline and no significant
changes occurred over the 12-month study period
(Table I). As expected, ABI values were higher in the CON
group (P  .001) than both PAD-IC groups (Table I). ABI
measures indicated an equal number of right and left side
index (worst) legs. Both PAD-IC groups included a higher
proportion of former smokers (P  .05) compared with the
CON group. The CPAD-IC group contained a higher
proportion of patients who had been prescribed beta-
blockermedication (P .05) compared with the TPAD-IC
and CON groups (Table I).
Lower limbmobility. There were significant between
group differences for stride length, cadence, stride time,
contact time, speed, and reduced double support time (1
and 2) for the CON group compared with the CPAD-IC
and TPAD-IC groups (Table II). There were no significant
differences between the CPAD-IC and TPAD-IC groups at
0 and 12 months for all temporal-spatial gait parameters
and gait kinematics. The 12-month supervised exercise
program had no significant impact on the temporal-spatial
gait parameters or gait kinematics of the TPAD-IC partic-
ipants (Table II).
Treadmill testing. The CON group demonstrated
significantly greater MWT compared with the TPAD-IC
and CPAD-IC groups. PFWT and MWT were significantly
greater for the TPAD-IC group following the 12-month
supervised exercise program compared with the CPAD-IC
group (Table III). The TPAD-IC group also demonstrated
significantly improved PFWT and MWT at 12 months
compared with baseline. Significantly higher VO2peak and
HRpeak values were determined for CON group compared
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cise program had no significant effect on any of the physi-
ological responses (HRpeak, VO2peak, VEpeak, and RERpeak)
for the TPAD-IC group compared with the CPAD-IC and
CON groups (Table III).
Physical activity level. The CON group demon-
strated significantly greater physical activity levels (number
of steps, walk distance, and calorie expenditure) compared
with the PAD-IC groups over the 7-day pedometer record-
ing period (Table IV). The 12-month supervised exercise
program had no significant effect on the physical activity
levels of the TPAD-IC participants compared with the
CPAD-IC and CON participants outside the supervised
training sessions. However, at the end of the 12-month
exercise program, the TPAD-IC participants walked an
Table II. Mean (SD) temporal-spatial gait parameter va
Variable
CON (n  11)
0 mo 12 mo
Stride length (m)* 1.37 (0.15) 1.35 (0.13
Cadence (steps·min1) 116.1 (3.1) 114.8 (4.3)
Stride time (s)* 1.04 (0.03) 1.05 (0.04
Contact time (s)* 0.63 (0.02) 0.65 (0.02
Flight time (s) 0.41 (0.02) 0.40 (0.02
Single support contralateral (s) 0.41 (0.02) 0.39 (0.02
Single support ipsilateral (s) 0.40 (0.02) 0.39 (0.03
Double support 1 (s)* 0.12 (0.02) 0.14 (0.01
Double support 2 (s)* 0.11 (0.01) 0.13 (0.02
Speed (m·s1) 1.3 (0.2) 1.3 (0.1)
CON, Healthy age and mass matched controls; CPAD-IC, control peri
peripheral arterial disease-intermittent claudication patients; Stride length, d
a minute; Stride time, time taken to produce a stride; Contact time, time that
foot is not in contact with the floor; Single support, time that each foot is sp
feet on the floor; Speed, calculation of stride length and stride time.
*P  .01 between group CON vs CPAD-IC & TPAD-IC.
Table III. Mean (SD) walking performance and physiol
Variable
CON (n  11)
0 mo 12 mo
PFWT (sec) 115.9
MWT (sec) 1191.1 (436.1) 1180.9 (411.2) 283.2
HRpeak
(beats·min1)¶
141.4 (20.0) 131.7 (18.7) 119.4
VO2peak
(ml·kg1·min1)
35.3 (6.8) 29.5 (6.3) 19.8
VEpeak (L · min
1) 58.6 (22.5) 46.0 (8.9) 38.3
RERpeak 0.93 (0.07) 0.94 (0.07) 0.88
CON, Healthy age and mass matched controls; CPAD-IC, control peri
peripheral arterial disease-intermittent claudication patients; PFWT, pain free
VE, ventilation; RER, respiratory exchange ratio.
*P  .05 vs 0 mo.
†P  .01 vs 0 mo.
‡P  .05 vs CPAD-IC 12 mo.
§P  .01 vs CPAD-IC 12 mo.
P  .01 vs CON.
¶P  .01 between group CON vs CPAD-IC and TPAD-IC.additional 3.9 to 6.9 km · wk1.DISCUSSION
The purpose of this study was to investigate the effects
of a 12-month supervised exercise program on individuals
with PAD-IC. To our knowledge, this study was the first to
examine the lower limb mobility characteristics (temporal-
spatial gait parameters and gait kinematics) of individuals
with PAD-IC over a 12-month period. Because lower limb
mobility characteristics have been shown to predict func-
tional decline22-25 and fall risk,26-29 it is very important to
understand how PAD-IC affects patient lower limb mobil-
ity. The results of this study demonstrated that a 12-month
supervised exercise program did not alter the lower limb
mobility characteristics of PAD-IC patients. Gardner et al3
speculated that exercise programs could be used to improve
of participants
CPAD-IC (n  11) TPAD-IC (n  10)
0 mo 12 mo 0 mo 12 mo
.20 (0.16) 1.20 (0.17) 1.19 (0.16) 1.23 (0.11)
8.9 (6.7) 107.9 (8.3) 107.6 (7.4) 109.6 (6.1)
.11 (0.06) 1.11 (0.09) 1.12 (0.08) 1.10 (0.06)
.69 (0.05) 0.70 (0.06) 0.70 (0.05) 0.69 (0.04)
.42 (0.04) 0.41 (0.04) 0.42 (0.04) 0.41 (0.03)
.42 (0.04) 0.41 (0.04) 0.42 (0.04) 0.41 (0.03)
.41 (0.03) 0.41 (0.04) 0.40 (0.04) 0.40 (0.02)
.15 (0.02) 0.15 (0.02) 0.15 (0.03) 0.15 (0.02)
.13 (0.03) 0.14 (0.03) 0.15 (0.03) 0.14 (0.02)
1.1 (0.2) 1.1 (0.2) 1.1 (0.2) 1.1 (0.1)
l arterial disease-intermittent claudication patients; TPAD-IC, treatment
either foot moves during the gait cycle; Cadence, number of steps taken in
silateral foot is in contact with the floor; Flight time, time that the ipsilateral
contact with the floor by itself; Double support, time that is spent with both
al responses values of participants
D-IC (n  11) TPAD-IC (n  10)
12 mo 0 mo 12 mo
.5) 166.3 (89.4) 132.8 (61.1) 360.0 (188.3)*‡
3.3) 347.7 (206.1) 335.5 (140.2) 739.4 (311.2)†§
.4) 108.6 (12.8) 117.5 (18.4) 116.4 (19.7)
1) 19.7 (4.3) 18.3 (6.5) 18.5 (7.2)
.6) 39.7 (12.3) 45.4 (23.3) 43.9 (21.6)
14) 0.87 (0.09) 0.95 (0.16) 0.94 (0.09)
l arterial disease-intermittent claudication patients; TPAD-IC, treatment
ng time;MWT,maximal walking time;HR, heart rate; VO2, oxygen uptake;lues
) 1
10
) 1
) 0
) 0
) 0
) 0
) 0
) 0
phera
istance
the ip
ent inogic
CPA
0 mo
(99
(18
(15
(7.
(14
(0.
phera
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semble that of healthy age-matched controls. However,
this view was not supported by our data. Studies that have
reported increased lower limb mobility in healthy aged
populations were exercise intensity and dosage depen-
dant.30 Thus, the exercise intensity and dosage adopted for
the current study may not have been sufficient to elicit
improved lower limb mobility in the PAD-IC patients.
However, a more frequent or intense exercise program is
unlikely to be feasible in practice. As in other studies, we
were only able to recruit a small proportion of the popula-
tion of patients presenting with intermittent claudication
and a more intense exercise program would potentially
have made recruitment even more problematic.
Although lower limb mobility was not altered in
TPAD-IC participants, the 12-month supervised exercise
program produced significantly higher treadmill walking
performance compared with baseline and the CPAD-IC
participants at 12 months. This result is similar to previous
studies on the effects of exercise programs on walking
performance in this population.9,31,32 However, there was
no improvement in the physical activity levels (outside the
supervised exercise sessions) of patients undergoing super-
vised exercise as assessed by 7-day pedometer measure-
ments, although there was a trend in this direction (Table
IV). We also found no changes in physiological responses
(HRpeak, VO2peak, VEpeak, and RERpeak) for either of the
intervention groups. The lack of improvement in physio-
logical responses, especially VO2peak, may have been due to
the intermittent nature of the exercise program undertaken
by the TPAD-IC patients. These participants ceased walk-
ing when they reached a pain intensity of 3 to 4 on the CPS.
This exercise regime would have had a limited impact on
central adaptation processes underlying peak oxygen con-
sumption.
The results of this study show that lower limb mobility
and physiological responses may not be the mechanism
underlying improved walking performance in PAD-IC pa-
tients following a supervised exercise program. The mech-
anism may be peripheral in nature for example, improved
blood flow, mitochondrial oxidative capacity, skeletal mus-
cle diffusive capacity, capillary growth, and/or improved
oxygen perfusion in the area of the arterial obstruc-
tion.6,33-35 In our opinion, another plausible mechanism
could be the impact of adaptation to claudication pain with
Table IV. Mean (SD) 7-day physical activity levels value
Variable
CON (n  11)
0 mo 12 mo 0
Steps* 45603 (13157) 53037 (22473) 31008
Distance (km)* 30.2 (9.3) 36.2 (15.5) 16.3
Calories (kcal)* 1954.2 (693.7) 2044.6 (938.7) 1065.1
CON, Healthy age and mass matched controls; CPAD-IC, control peri
peripheral arterial disease-intermittent claudication patients.
*P  .01 between group CON vs CPAD-IC and TPAD-IC.PAD-IC patients becoming more tolerant of claudicationpain due to the progressive nature of exercise programs.
Also, lower limb mobility characteristics were only mea-
sured during pain free walking. Lower limb mobility may
alter during the gradual onset of claudication pain and/or
at maximal claudication pain levels.
CONCLUSION
The results of this study demonstrated that a 12-month
supervised exercise program results in improved walking
performance in PAD-IC patients but does not alter central
physiological characteristics during exercise, reported phys-
ical activity levels, or lower limb mobility during pain free
walking. Power values for the temporal-spatial gait param-
eters ranged from low to moderate for this sample size.
Future research should use larger sample sizes to increase
the power for these variables. The improved walking per-
formance may be due to peripheral physiological mecha-
nisms and the effects of intensity and dosage of exercise.
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